Between 10% and 20% of PNH patients experience clinically significant loss of red blood cells outside of the blood vessels, a condition known as extravascular haemolysis, and continued anemia symptoms when on C5 inhibitors
MACEs: eventos adversos cardiovasculares mayores
ICH Q1A(R2), Q2(R2), Q3A, Q3B, Q3C, Q5C, and Q6B
By the time we are in our 40's, our HGH levels diminish by 40% of what it was at age 20, and as we continue to age, those HGH levels continue to decrease dramatically
Not all HRT formulations carry the same risk profile, and those differences are clinically significant in the context of the cardiometabolic goals this combination approach is designed to serve
Setting realistic expectations and following up with a qualified physician can help ensure that the treatment aligns safely with personal goals